Experimental study on the treatment of ulcerative colitis with the combination of Tongxiening granule and Mesalazine
10.3969/j.issn.1671-8348.2016.30.027
- VernacularTitle:痛泻宁颗粒联合美沙拉秦口服治疗溃疡性结肠炎的疗效观察
- Author:
Guodong HUANG
;
Yan WU
;
Peng LIAO
;
Yuanhua HUANG
;
Qian LI
;
Shanfei GE
;
Yu YOU
;
Wenjuan MEI
- Publication Type:Journal Article
- Keywords:
colitis,ulcerative;
mesalazine;
Tongxiening granules;
clinical effects observation
- From:
Chongqing Medicine
2016;45(30):4261-4264
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical effect of combination of Tongxiening granule and Mesalazine on treating mild and moderate ulcerative colitis(UC) .Methods Totally 380 patients with mild‐to‐moderate UC diagnosed through endoscopy were allocated to the control group (n=190) and observation group(n=190) .For the observation group ,patients were remedied with the combination of Tongxiening Granules and the Mesalazine by oral administration for eight weeks ,meanwhile the control group only received the Mesalazine for eight weeks .The total effective rate of the two groups were statistically analyzed ,and the levels of ser‐um MMP‐2 and MMP‐9 before and after treatment in the two groups were measured .The expression of S100A12 and RAGE were detected by immunohistochemistry SP method .Results The total effective rate of the observation group and the control group was 94 .74% and 89 .47% respectively ,and the difference was statistically significant(P<0 .01) .After treatment ,the expression levels of MMP‐2 and MMP‐9 in the two groups were decreased ,additionally the expression levels in the observation group was lower than those in the control group ,and the difference was statistically significant (P< 0 .01) .After treatment ,the expression levels of RAGE and S100A12 in the observation group were decreased ,and there was a significant difference when compared with the control group(P<0 .01) .Conclusion Combined application of Tongxiening Granules and Mesalazine in treating patients with mild‐to‐mod‐erate UC could better improve clinical symptoms and bring better therapeutic effect than single use of Mesalazine .
